Literature DB >> 22171532

A longitudinal analysis of the lifetime cost of dementia.

Zhou Yang1, Kun Zhang, Pei-Jung Lin, Carolyn Clevenger, Adam Atherly.   

Abstract

OBJECTIVE: Estimate the lifetime cost of dementia to Medicare and Medicaid. DATA SOURCE: 1997-2005 Medicare Current Beneficiary Survey. STUDY
DESIGN: A multistage analysis was conducted to first predict the probability of developing dementia by age and then predict the annual Medicare/Medicaid expenditures conditional on dementia status. A cohort-based simulation was conducted to estimate the lifetime cost of dementia. PRINCIPAL
FINDINGS: The average lifetime cost of dementia per patient for Medicare is approximately $12,000 (2005 dollars) and for Medicaid about $11,000. Dementia onset at older age leads to shorter duration and lower lifetime cost. Increased educational level leads to longer longevity, more dementia cases per cohort, but shorter duration, and lower lifetime cost per patient, which could offset the cost increase induced by more dementia cases. Increased body mass index leads to more dementia cases per cohort and higher lifetime cost per patient.
CONCLUSION: Net cost of dementia is lower than the estimates from cross-sectional studies. Promoting healthy lifestyle to reverse the obesity epidemic is a short-term priority to confront the epidemic of dementia in the near future. Promoting higher education among the younger generation is a long-term priority to mitigate the effect of population aging on the dementia epidemic in the distant future. © Health Research and Educational Trust.

Entities:  

Mesh:

Year:  2011        PMID: 22171532      PMCID: PMC3307859          DOI: 10.1111/j.1475-6773.2011.01365.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  27 in total

1.  Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare.

Authors:  J W Hill; R Futterman; S Duttagupta; V Mastey; J R Lloyd; H Fillit
Journal:  Neurology       Date:  2002-01-08       Impact factor: 9.910

2.  Enrolling people with prediabetes ages 60-64 in a proven weight loss program could save Medicare $7 billion or more.

Authors:  Kenneth E Thorpe; Zhou Yang
Journal:  Health Aff (Millwood)       Date:  2011-09       Impact factor: 6.301

Review 3.  The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances.

Authors:  Philip D Sloane; Sheryl Zimmerman; Chirayath Suchindran; Peter Reed; Lily Wang; Malaz Boustani; S Sudha
Journal:  Annu Rev Public Health       Date:  2001-10-25       Impact factor: 21.981

Review 4.  Education and the prevalence of dementia and Alzheimer's disease.

Authors:  R Katzman
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

5.  Epidemiology, education, and the ecology of Alzheimer's disease.

Authors:  R P Friedland
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

6.  Survival following a diagnosis of Alzheimer disease.

Authors:  Ron Brookmeyer; Maria M Corrada; Frank C Curriero; Claudia Kawas
Journal:  Arch Neurol       Date:  2002-11

7.  Methods for projecting the incidence and prevalence of chronic diseases in aging populations: application to Alzheimer's disease.

Authors:  R Brookmeyer; S Gray
Journal:  Stat Med       Date:  2000 Jun 15-30       Impact factor: 2.373

8.  Health insurance and the demand for medical care: evidence from a randomized experiment.

Authors:  W G Manning; J P Newhouse; N Duan; E B Keeler; A Leibowitz; M S Marquis
Journal:  Am Econ Rev       Date:  1987-06

9.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

10.  Survival after initial diagnosis of Alzheimer disease.

Authors:  Eric B Larson; Marie-Florence Shadlen; Li Wang; Wayne C McCormick; James D Bowen; Linda Teri; Walter A Kukull
Journal:  Ann Intern Med       Date:  2004-04-06       Impact factor: 25.391

View more
  19 in total

1.  Medicaid Contributes Substantial Costs to Dementia Care in an Ethnically Diverse Community.

Authors:  Carolyn W Zhu; Katherine A Ornstein; Stephanie Cosentino; Yian Gu; Howard Andrews; Yaakov Stern
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-08-13       Impact factor: 4.077

2.  Olfactory identification deficits and increased mortality in the community.

Authors:  Davangere P Devanand; Seonjoo Lee; Jennifer Manly; Howard Andrews; Nicole Schupf; Arjun Masurkar; Yaakov Stern; Richard Mayeux; Richard L Doty
Journal:  Ann Neurol       Date:  2015-07-03       Impact factor: 10.422

3.  Association of Sensory and Cognitive Impairment With Healthcare Utilization and Cost in Older Adults.

Authors:  William James Deardorff; Phillip L Liu; Richard Sloane; Courtney Van Houtven; Carl F Pieper; Susan Nicole Hastings; Harvey J Cohen; Heather E Whitson
Journal:  J Am Geriatr Soc       Date:  2019-03-29       Impact factor: 5.562

4.  Direct medical costs and source of cost differences across the spectrum of cognitive decline: a population-based study.

Authors:  Cynthia L Leibson; Kirsten Hall Long; Jeanine E Ransom; Rosebud O Roberts; Steven L Hass; Amy M Duhig; Carin Y Smith; Jane A Emerson; V Shane Pankratz; Ronald C Petersen
Journal:  Alzheimers Dement       Date:  2015-04-06       Impact factor: 21.566

5.  Societal and Family Lifetime Cost of Dementia: Implications for Policy.

Authors:  Eric Jutkowitz; Robert L Kane; Joseph E Gaugler; Richard F MacLehose; Bryan Dowd; Karen M Kuntz
Journal:  J Am Geriatr Soc       Date:  2017-08-17       Impact factor: 5.562

6.  Interactive Effects of Dementia Severity and Comorbidities on Medicare Expenditures.

Authors:  Carolyn W Zhu; Stephanie Cosentino; Katherine A Ornstein; Yian Gu; Howard Andrews; Yaakov Stern
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 7.  Direct and indirect cost of managing alzheimer's disease and related dementias in the United States.

Authors:  Arijita Deb; James Douglas Thornton; Usha Sambamoorthi; Kim Innes
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2017-04       Impact factor: 2.217

8.  Medicare expenditures attributable to dementia.

Authors:  Lindsay White; Paul Fishman; Anirban Basu; Paul K Crane; Eric B Larson; Norma B Coe
Journal:  Health Serv Res       Date:  2019-03-13       Impact factor: 3.402

9.  Direct medical expenditures associated with Alzheimer's and related dementias (ADRD) in a nationally representative sample of older adults - an excess cost approach.

Authors:  Arijita Deb; Usha Sambamoorthi; James Douglas Thornton; Bernard Schreurs; Kim Innes
Journal:  Aging Ment Health       Date:  2017-02-08       Impact factor: 3.658

10.  Service Availability in Assisted Living and Other Community-Based Residential Settings at the End of Life.

Authors:  Melissa D Aldridge; Katherine A Ornstein; Karen McKendrick; Jennifer Reckrey
Journal:  J Palliat Med       Date:  2021-04-07       Impact factor: 2.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.